BioJapan 2027
Dates taking place: October 2027 (exact dates to be announced)
Location: PACIFICO Yokohama, Yokohama, Japan
Some events find their location and the relationship makes immediate sense. The industry, the city and the particular quality of a gathering that belongs where it is held rather than merely happening there. BioJapan and Yokohama have that relationship. PACIFICO on the Minato Mirai waterfront. The Japanese biotech ecosystem and the global industry that has been paying increasing attention to what Asia is producing and that comes to Yokohama in October to do something about that attention.
BioJapan 2027 returns in October. Three days. The partnering that is the core of the event. The exhibition that makes the ecosystem visible. The content that gives both context. Yokohama in autumn providing the setting that the event deserves and the city that the setting belongs to.
The relationships from 2026 at the starting point for 2027's conversations. The Japanese biotech assets that were in development last October further along this October. The global industry returning with the understanding that the Asian biotech market is not a future consideration but a current one and that BioJapan is where the current conversation is most productively had.
The Partnering.
BioJapan partnering system in 2027 operates with the accumulated benefit of the previous edition behind it. The meetings initiated in 2026 are the partnerships being developed in 2027. The licensing conversations that began at PACIFICO last October are the agreements being finalised or the collaborations being extended this October.
New meetings alongside the continuing ones and new companies bringing new assets to the partnering system. New global participants arriving at BioJapan for the first time with the recommendations of those who came in 2026 behind the decision.
Japanese pharmaceutical and biotech ecosystem keeps producing. Universities keep generating science. Biotech companies keep developing assets. The global companies keep arriving in Yokohama in October because BioJapan keeps delivering what they came for — the concentrated partnering access to the Asian biotech market that the rest of the year provides slowly and incompletely.
Three days in October. The meetings that matter. The results that follow.
If you need help with your next event, incentive, meeting, conference or group to Japan, please
The Exhibition. The Ecosystem in 2027.
The BioJapan floor in 2027 reflects the Asian biotech ecosystem as it stands in October of that year. New companies alongside returning ones. The Japanese drug developers whose assets are further along than they were in 2026. The Korean and Taiwanese and broader Asian participants whose presence confirms that BioJapan's reach extends beyond its Japanese core.
The international pharmaceutical companies returning with the understanding of the market that 2026 produced and the specific requirements that the year since has refined. The technology platform companies presenting the capabilities that the development-stage companies need. The contract research and manufacturing organisations whose services connect the ecosystem's innovation to its implementation.
The floor visible progress from year to year. The returning attendee in 2027 sees what has changed from 2026. The new arrivals see the ecosystem at full expression. Both visits are productive. Both produce the understanding that the partnering meetings benefit from.
The Content. The 2027 Context.
The BioJapan programme in 2027 covers the Asian biotech and pharmaceutical landscape as it stands in October of that year. The regulatory developments at the PMDA and across the Asian agencies. The innovation coming from the Japanese and broader Asian research base. The investment environment for Asian biotech in 2027. The partnership models producing results in the current market.
Speakers who know the Japanese and Asian industry from inside it. Content that reflects where the market actually is rather than where it was when someone last updated the slide deck. The sessions that give the partnering meetings context and that give the global participants the understanding of the Japanese market that productive partnerships require.
Three days. Focused. The reliable outcome — the participant who arrived with specific partnering objectives and leaves with specific progress toward them.
Yokohama in October. Still the Right Setting.
The Minato Mirai waterfront in October. The autumn colours arriving across the bay. The temperature in the range that makes the evening walk along the waterfront a natural conclusion to the conference day rather than an obligation.
PACIFICO Yokohama in October is PACIFICO Yokohama in its best season — the light on the water in the early evening, the bay development doing what it does in autumn, which is look exactly right. The convention centre handling the event with the practiced ease of a venue that has been doing this for years.
Chinatown for the dinner that deviates productively from the convention hotel. Motomachi for the morning that wants the Yokohama that the waterfront development doesn't show. The harbour promenade for the evening between sessions when the bay earns twenty minutes of attention.
Tokyo thirty minutes away by train. Still close enough to use. Still far enough that Yokohama remains itself rather than a satellite of the larger city. The extension before or after BioJapan that Japan in October justifies and that clients who have come this far are increasingly willing to take.
October in Japan. The autumn colours. The food. The particular quality of a Japanese city in autumn that no other convention destination provides and that clients who have experienced it reference for years afterwards.
For DMCs and Incentive Planners
For travel professionals, BioJapan 2027 has the same compelling proposition — three days of the most concentrated Asian biotech partnering event in the calendar at PACIFICO Yokohama, with Japan in October providing everything around it.
The clients who attended in 2026 are returning with the relationships from the previous edition already in progress. The clients attending for the first time in 2027 are arriving with the recommendations of those who came before. Both groups find Yokohama ready and BioJapan delivering what it has always delivered.
The pre-event arrival in Tokyo. The Shinkansen south to Yokohama. The days at PACIFICO. The evenings on the Minato Mirai waterfront. The extension that Japan in October always justifies — Kyoto for the autumn colours, Osaka for the food, the wider Japan that a journey of this distance deserves.
For incentive groups within the biotech and pharmaceutical sector, BioJapan 2027 delivers the combination that the 2026 edition established — the professional substance of the most focused Asian biotech partnering event alongside Japan in October. The country, the culture, the food and the waterfront city that no European or American convention destination approaches in terms of what the visit leaves behind.
The partnering is at PACIFICO. Japan is everywhere else. Both are worth the journey. Year two confirms what year one established.
Which is that BioJapan in Yokohama in October is worth coming back for. The industry keeps coming back. The conclusion is correct.
For more information about the event visit this page.
If you would like to see more events like these visit our events page!
Disclaimer:
We have researched the dates of this event for you. However, before you plan and book, please always check with the event organiser directly to see if there have been any changes and if the event still takes place.
